Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 2/20 | 0.70 |
| ▸ | SELL | P14151 | 1/20 | 0.70 |
| ▸ | MAG | P20916 | 6/20 | 0.63 |
| ▸ | SELE | P16581 | 5/20 | 0.62 |
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14518953 | 1.00 | SELP (0.70) | SELPSELLMAGSELESIGLEC7 | |
| SCHEMBL14268468 | 1.00 | SELP (0.70) | SELPSELLMAGSELESIGLEC7 | |
| SCHEMBL14329823 | 0.95 | SELP (0.64) | SELPSELLMAGSELESIGLEC7 | |
| SCHEMBL14329822 | 0.95 | SELP (0.64) | SELPSELLMAGSELESIGLEC7 | |
| SCHEMBL13541587 | 0.94 | SELP (0.72) | SELPSELLMAGSELESIGLEC7 | |
| SCHEMBL22763983 | 0.94 | SELP (0.72) | SELPSELLMAGSELESIGLEC7 | |
| SCHEMBL19453264 | 0.94 | SELE (0.70) | SELPSELLMAGSELESIGLEC7 | |
| SCHEMBL31010809 | 0.94 | SELP (0.71) | SELPSELLMAGSELESIGLEC7 | |
| SCHEMBL29407985 | 0.94 | SELP (0.71) | SELPSELLMAGSELESIGLEC7 | |
| SCHEMBL13195877 | 0.94 | SELP (0.73) | SELPSELLMAGSELESIGLEC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120328603-A1 | ASSAYS AND METHODS USING BIOMARKERS | GENENTECH, INC. (US) | 2012-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120328603-A1 | ASSAYS AND METHODS USING BIOMARKERS | FUT4, FUT6, FUT8 | SELP 166/4885SELL 135/4885MAG 962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.